Please select the outcome measures that correspond to the clinical trial below.
Title: An Intervention Program to Reduce NCD Related Behavioral Risk Factor Among Adolescents in Institutional Settings of Bangladesh
Brief Summary: This is a before-after designed intervention study conducted in two randomly selected secondary schools- one was selected randomly as intervention school and the another as control school. A baseline survey was conducted among the students of both schools by a pre-tested questionnaire to attain their current status of knowledge, attitude and practices related to NCDs. Afterward, students were enrolled in the intervention group who met the eligibility criteria from the intervention school. The intervention was given through a health promotion session to a group of students, not more than 25 at a time, by trained facilitators. A post-intervention end line survey was conducted among all the participants from both schools using the same questionnaire three months after the baseline survey. An intervention has been developed based on some principals of two psychosocial theory- Motivational Interview and Social Cognitive Theory. Emphasis was given on motivating the adolescents towards a healthy lifestyle, supporting self-efficacy to be changed, guiding self-regulatory ways along with facilitating desired changing process by empowering them with choices about the preventive measures of NCDs. This intervention is expected to increase awareness by equipping the adolescents with specific knowledge and skills and thus, facilitate an eventual change in their practiced risk behaviors.


Options:
A: Mean Change From Baseline In Body Mass Index At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Glucose Profile At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Glycated Haemoglobin At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Triglycerides At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Total Cholesterol At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting High Density Lipoprotein Cholesterol At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Low Density Lipoproteins Cholesterol At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Creatinine At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Urea At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Urea Nitrogen At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Uric Acid At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Glutamic Oxalacetic Transaminase At 12 Weeks. (Up to 12 weeks); Mean Change From Baseline In Fasting Glutamic Pyruvic Transaminase, At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Fasting Bilirubin Profile, At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Indirect Of Maximum Oxygen Consumption At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Speed At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Strength-Resistance At 12 Weeks (Up to 12 weeks); Mean Change From Baseline In Power At 12 Weeks (Up to 12 weeks)
B: Academic performance (October 2014 - June 2015 (8 months))
C: Changes in the composite ICH score of adolescents from baseline to year 2 and 4 (2 and 4 years)
D: Change in knowledge (Three months); Change in attitude (Three months); Change in practice (Three months)

Answer: D